Viveve Medical Stock Performance
| VIVE Stock | USD 0.0002 0.00 0.00% |
Viveve Medical holds a performance score of 13 on a scale of zero to a hundred. The entity has a beta of -12.25, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Viveve Medical are expected to decrease by larger amounts. On the other hand, during market turmoil, Viveve Medical is expected to outperform it. Use Viveve Medical risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis , to analyze future returns on Viveve Medical.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Viveve Medical are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Viveve Medical exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 6.5 M | |
| Total Cashflows From Investing Activities | -456 K |
Viveve |
Viveve Medical Relative Risk vs. Return Landscape
If you would invest 0.01 in Viveve Medical on November 2, 2025 and sell it today you would earn a total of 0.01 from holding Viveve Medical or generate 100.0% return on investment over 90 days. Viveve Medical is currently generating 26.9713% in daily expected returns and assumes 163.1376% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Viveve, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Viveve Medical Target Price Odds to finish over Current Price
The tendency of Viveve Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0002 | 90 days | 0.0002 | about 42.45 |
Based on a normal probability distribution, the odds of Viveve Medical to move above the current price in 90 days from now is about 42.45 (This Viveve Medical probability density function shows the probability of Viveve Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Viveve Medical has a beta of -12.25. This entails as returns on its benchmark rise, returns on holding Viveve Medical are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Viveve Medical is expected to outperform its benchmark. In addition to that Viveve Medical has an alpha of 12.3187, implying that it can generate a 12.32 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Viveve Medical Price Density |
| Price |
Predictive Modules for Viveve Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Viveve Medical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Viveve Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Viveve Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Viveve Medical is not an exception. The market had few large corrections towards the Viveve Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Viveve Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Viveve Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 12.32 | |
β | Beta against Dow Jones | -12.25 | |
σ | Overall volatility | 0.0002 | |
Ir | Information ratio | 0.12 |
Viveve Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Viveve Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Viveve Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Viveve Medical is way too risky over 90 days horizon | |
| Viveve Medical has some characteristics of a very speculative penny stock | |
| Viveve Medical appears to be risky and price may revert if volatility continues | |
| Viveve Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 6.43 M. Net Loss for the year was (22.03 M) with profit before overhead, payroll, taxes, and interest of 620 K. | |
| Viveve Medical currently holds about 9.43 M in cash with (12.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.88, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Viveve Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Viveve Pink Sheet often depends not only on the future outlook of the current and potential Viveve Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Viveve Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.1 M | |
| Cash And Short Term Investments | 19.2 M |
Viveve Medical Fundamentals Growth
Viveve Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Viveve Medical, and Viveve Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Viveve Pink Sheet performance.
| Return On Equity | -2.11 | |||
| Return On Asset | -0.62 | |||
| Operating Margin | (3.10) % | |||
| Current Valuation | 4.26 M | |||
| Shares Outstanding | 10.72 M | |||
| Price To Earning | (2.59) X | |||
| Price To Book | 3.62 X | |||
| Price To Sales | 0.66 X | |||
| Revenue | 6.43 M | |||
| EBITDA | (19.89 M) | |||
| Cash And Equivalents | 9.43 M | |||
| Cash Per Share | 0.88 X | |||
| Total Debt | 5.12 M | |||
| Debt To Equity | 1.12 % | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (12.88 M) | |||
| Earnings Per Share | (2.55) X | |||
| Total Asset | 25.91 M | |||
| Retained Earnings | (68.62 M) | |||
| Current Asset | 18.53 M | |||
| Current Liabilities | 5.32 M | |||
About Viveve Medical Performance
By analyzing Viveve Medical's fundamental ratios, stakeholders can gain valuable insights into Viveve Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Viveve Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Viveve Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado. Viveve Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.Things to note about Viveve Medical performance evaluation
Checking the ongoing alerts about Viveve Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Viveve Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Viveve Medical is way too risky over 90 days horizon | |
| Viveve Medical has some characteristics of a very speculative penny stock | |
| Viveve Medical appears to be risky and price may revert if volatility continues | |
| Viveve Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 6.43 M. Net Loss for the year was (22.03 M) with profit before overhead, payroll, taxes, and interest of 620 K. | |
| Viveve Medical currently holds about 9.43 M in cash with (12.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.88, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Viveve Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Viveve Medical's stock is overvalued or undervalued compared to its peers.
- Examining Viveve Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Viveve Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Viveve Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Viveve Medical's pink sheet. These opinions can provide insight into Viveve Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Viveve Pink Sheet analysis
When running Viveve Medical's price analysis, check to measure Viveve Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viveve Medical is operating at the current time. Most of Viveve Medical's value examination focuses on studying past and present price action to predict the probability of Viveve Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viveve Medical's price. Additionally, you may evaluate how the addition of Viveve Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |